Independent Advisor Alliance’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,848
Closed -$178K 712
2023
Q3
$178K Hold
18,848
0.01% 618
2023
Q2
$263K Hold
18,848
0.01% 556
2023
Q1
$354K Buy
18,848
+1,500
+9% +$24.6K 0.02% 485
2022
Q4
$239 Buy
17,348
+500
+3% +$7.66K ﹤0.01% 371
2022
Q3
$322K Hold
16,848
0.02% 466
2022
Q2
$257K Buy
16,848
+600
+4% +$8.87K 0.01% 522
2022
Q1
$331K Buy
16,248
+2,000
+14% +$40.7K 0.02% 489
2021
Q4
$416K Hold
14,248
0.02% 438
2021
Q3
$307K Hold
14,248
0.02% 483
2021
Q2
$365K Buy
+14,248
New +$304K 0.02% 465

Other funds holding CDMO

Independent Advisor Alliance's CDMO Position: Q4 2023 in Review

Independent Advisor Alliance sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 18,848 shares — an estimated $178K sold.

Independent Advisor Alliance first reported a position in CDMO in Q2 2021 and held it in 10 quarters. The position peaked at $416K in Q4 2021. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Independent Advisor Alliance reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Independent Advisor Alliance sold 18,848 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $178K.
  • Independent Advisor Alliance first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Independent Advisor Alliance's Avid Bioservices, Inc. Common Stock position peaked at $416K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Independent Advisor Alliance's 13F filing for Q4 2023, filed 8 Feb 2024.